Quote Of The Month
"Everyone has a doctor in him or her; we just have to help it in its work. The natural healing force within each one of us is the greatest force in getting well. Our food should be our medicine. Our medicine should be our food. But to eat when you are sick, is to feed your sickness" 
 
-Hippocrates
 Greek physician
 (460 BC - 377 BC)
NFH Sponsored By

Vitacost.com

Vision Direct

Welcome!
At NFH we strive to empower you to take control of your own health and fitness through nutrition, prevention of disease, and natural healing.  NFH was started by Breast Cancer Survivor and career long Registered Nurse, Sue Macco.
« Black Raspberries Protect Against Cancer | Main | Topical Vitamin C Stops Basal Cell Carcinoma »
Friday
22Feb

IV Vitamin C Toxic To Cancer Cells

1154312-1425989-thumbnail.jpgIntravenous Vitamin C is Selectively Toxic to Cancer Cells

(OMNS) National Institutes of Health scientists have confirmed the concepts that vitamin C is selectively toxic to cancer cells and that tumor-toxic levels of vitamin C can be attained using intravenous administration. The article, published in the September 12, 2005 issue of the Proceedings of the National Academy of Sciences (1) concluded, “These findings give plausibility to intravenous ascorbic acid in cancer treatment.”

Orthomolecular medical researchers, including Nobel laureate Linus Pauling, have long recognized the great importance of vitamin C in fighting cancer. (2) Scientists associated with the Bio-Communications Research Institute (BRCI) in Wichita, Kansas have published 20 scientific articles on the subject. (3) BCRI researchers first reported in 1995 that vitamin C in sufficient amounts is selectively toxic to tumor cells. The authors concluded that tumor-toxic levels of vitamin C could be achieved only by giving the vitamin intravenously. Subsequent research from BCRI, published in the British Journal of Cancer in 2001 (4), was the first to describe in detail the pharmacokinetics of high doses of intravenous vitamin C.

"It is gratifying to have our research on vitamin C and cancer confirmed by scientists at the prestigious National Institutes of Health," said Neil Riordan, Ph.D., BCRI’s Research Director. “The findings reinforce our goal and commitment to pursue cutting edge cancer research,” added Michael Gonzalez, Ph.D., D.Sc. of the University of Puerto Rico.

BCRI’s vitamin C research was headed by its founder Hugh D. Riordan, M.D. The research team includes Dr. Xiaolong Meng, Dr. Joseph Casciari, Dr. Nina Mikirova, Dr. Jie Zhong, Dr. James A. Jackson, Dr. Don Davis, Dr. Jorge Miranda, Dr. Michael Gonzalez, Dr. Neil Riordan, and Mr. Paul Taylor.

What is Orthomolecular Medicine?

Linus Pauling defined orthomolecular medicine as "the treatment of disease by the provision of the optimum molecular environment, especially the optimum concentrations of substances normally present in the human body." Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Take the Orthomolecular Quiz at http://www.orthomolecular.org/quiz/index.shtml

Article from Orthomolecular Medicine News Service, September 22, 2005

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:
Abram Hoffer, M.D., Ph.D.
Harold D. Foster, Ph.D.
Bradford Weeks, M.D.
Carolyn Dean, M.D. N.D.
Erik Paterson, M.D.

Andrew W. Saul, Ph.D.,


PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>